CA2338996A1 - Composition pharmaceutique ayant un gout ameliore - Google Patents

Composition pharmaceutique ayant un gout ameliore Download PDF

Info

Publication number
CA2338996A1
CA2338996A1 CA002338996A CA2338996A CA2338996A1 CA 2338996 A1 CA2338996 A1 CA 2338996A1 CA 002338996 A CA002338996 A CA 002338996A CA 2338996 A CA2338996 A CA 2338996A CA 2338996 A1 CA2338996 A1 CA 2338996A1
Authority
CA
Canada
Prior art keywords
drug
pharmaceutical composition
gelling agent
composition according
containing substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002338996A
Other languages
English (en)
Inventor
Yoshinao Onishi
Hirofumi Doi
Masaaki Odomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2338996A1 publication Critical patent/CA2338996A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne une composition pharmaceutique comprenant une substance contenant un médicament dans laquelle le goût désagréable du médicament est masqué, ainsi qu'un agent gélifiant. Ladite composition pharmaceutique est convertie en préparation du type gelée, constituée de ladite substance contenant un médicament, dispersée dans celle-ci par dissolution dans l'eau. Le goût désagréable du médicament de ladite composition pharmaceutique, à savoir, entre autres, l'amertume, l'acidité ou l'aigreur, est réduit et la prise dudit médicament est plus facile.
CA002338996A 1998-07-31 1999-07-26 Composition pharmaceutique ayant un gout ameliore Abandoned CA2338996A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21751798 1998-07-31
JP10/217517 1998-07-31
PCT/JP1999/004046 WO2000006122A1 (fr) 1998-07-31 1999-07-26 Composition pharmaceutique ayant un gout ameliore

Publications (1)

Publication Number Publication Date
CA2338996A1 true CA2338996A1 (fr) 2000-02-10

Family

ID=16705487

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002338996A Abandoned CA2338996A1 (fr) 1998-07-31 1999-07-26 Composition pharmaceutique ayant un gout ameliore

Country Status (10)

Country Link
EP (1) EP1100466A1 (fr)
KR (1) KR20010072151A (fr)
CN (1) CN1161106C (fr)
AR (1) AR019485A1 (fr)
AU (1) AU4802699A (fr)
BR (1) BR9912533A (fr)
CA (1) CA2338996A1 (fr)
HK (1) HK1040191A1 (fr)
ID (1) ID28910A (fr)
WO (1) WO2000006122A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002254036A1 (en) 2001-03-05 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
BR0207930A (pt) 2001-03-05 2004-03-02 Ortho Mcneil Pharm Inc Composições farmacêuticas lìquidas com sabor mascarado
ATE454906T1 (de) * 2003-07-11 2010-01-15 Astrazeneca Ab Feste zusammensetzung mit einem protonenpumpenhemmer
CN100435847C (zh) * 2004-05-13 2008-11-26 宝龄富锦生技股份有限公司 含有难溶解性主药之持续释放配方
US9161557B2 (en) 2004-06-07 2015-10-20 Kureha Corporation Dry composition for oral ingestion and gel composition prepared just before use for oral ingestion
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
BR112012030023A2 (pt) * 2010-05-24 2016-08-02 Amerilab Technologies Inc composição efervescente para formação de uma composição gelificada, comprimido para formação de composição gelificada e método para fabricação de uma composição gelificada
CN103813807B (zh) 2011-09-30 2017-02-08 持田制药株式会社 易服用性固体制剂
SG10202109130WA (en) * 2017-02-21 2021-09-29 Ea Pharma Co Ltd Granular preparation
FR3101546B1 (fr) 2019-10-07 2023-11-10 Roquette Freres Masquage du goût de l’isosorbide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
US5972373A (en) * 1995-05-02 1999-10-26 Taisho Pharmaceutical Co., Ltd. Taste masking pharmaceutical composition for oral administration
EA000467B1 (ru) * 1995-07-21 1999-08-26 Дайити Фармасьютикал Ко., Лтд. Гранулированный препарат и способ его получения
CA2227314A1 (fr) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Fabrication de preparations a saveur dissimulee contenant des derives de quinolones actifs du point de vue antibacterien

Also Published As

Publication number Publication date
EP1100466A1 (fr) 2001-05-23
CN1316899A (zh) 2001-10-10
CN1161106C (zh) 2004-08-11
BR9912533A (pt) 2002-02-13
AR019485A1 (es) 2002-02-20
KR20010072151A (ko) 2001-07-31
HK1040191A1 (zh) 2002-05-31
ID28910A (id) 2001-07-12
AU4802699A (en) 2000-02-21
WO2000006122A1 (fr) 2000-02-10

Similar Documents

Publication Publication Date Title
EP0984774B1 (fr) Microspheres de retention gastrique a liberation regulee assurant une meilleure administration de medicaments
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
US7547451B2 (en) Pellet formulation for the treatment of the intestinal tract
JP2000509399A (ja) 味隠蔽された懸濁液
HU227381B1 (en) Pharmaceutical composition containing slightly water-soluble drugs with immediate release core and instained release coating
JP2003508428A (ja) 徐放される経口医薬投薬形
KR20000069899A (ko) 속방성 및 미각 차폐성 약제학적 용량 형태
IL177402A (en) Composition for oral administration of tamsulosin hydrochloride
JP2000103730A (ja) 服用感が改善された医薬組成物
WO2002096466A1 (fr) Composition de medicament
RU2237480C2 (ru) Непосредственно прессуемая матрица для регулируемого высвобождения однократных ежедневных доз кларитромицина
AU2005261958A1 (en) Granules for controlled release of Tamsulosin
CA2338996A1 (fr) Composition pharmaceutique ayant un gout ameliore
EP0378137A2 (fr) Forme galénique
JP2000191519A (ja) 薬効成分の不快な官能的性質が隠蔽された速放性粒状物
JP5046463B2 (ja) 徐放性医薬組成物
US7063864B1 (en) Morphine sulphate microgranules, method for preparing same and compositions containing same
JP2007518670A (ja) 苦味のある薬物、及びｐＨ感受性ポリマーを含む風味マスクされた医薬組成物
EP1194124B1 (fr) Compositions a gout masque
JP3833314B2 (ja) 発泡性組成物およびその製造方法
US7060293B1 (en) Powder-layered oral dosage forms
AU732210B2 (en) Colonic delivery of weak acid drugs
JP3466921B2 (ja) 味マスキング医薬製剤
KR101680925B1 (ko) 불쾌미 마스킹 입자 및 이것을 함유하는 경구제제
EP1600157A1 (fr) Particules fines keratinisees pour la liberation prolongee de tamsulosine ou de son sel, et leur procede de production

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead